Tag: GCP compliance

Group-Sequential Designs: Statistical Concepts and Practical Execution

Posted on By digi

Group-Sequential Designs: Statistical Concepts and Practical Execution Group-Sequential Designs: Statistical Concepts and Practical Execution In the landscape of clinical trials, the need for efficiency and ethical considerations is paramount. Group-sequential designs provide robust statistical methodologies that allow researchers to conduct interim analyses, ensuring that clinical trials can be adapted based on accumulating data. This article…

Read More “Group-Sequential Designs: Statistical Concepts and Practical Execution” »

Interim Analyses & Alpha Spending

Surveillance in DCT and eSource-Heavy Trials With High-Volume Data

Posted on By digi

Surveillance in DCT and eSource-Heavy Trials With High-Volume Data Surveillance in DCT and eSource-Heavy Trials With High-Volume Data The integration of Digital Clinical Trials (DCT) and eSource methodologies has transformed the landscape of clinical research, particularly for trials involving high-volume data. This article serves as a comprehensive tutorial aimed at clinical operations, regulatory affairs, and…

Read More “Surveillance in DCT and eSource-Heavy Trials With High-Volume Data” »

Statistical Data Surveillance

Documenting Statistical Surveillance Methods in Protocol and SAP

Posted on By digi

Documenting Statistical Surveillance Methods in Protocol and SAP Documenting Statistical Surveillance Methods in Protocol and SAP Statistical surveillance is a critical component in ensuring the integrity and validity of clinical trial data, particularly in the conduct of sma clinical trials. Proper documentation of statistical surveillance methods in both the Trial Protocol and Statistical Analysis Plan…

Read More “Documenting Statistical Surveillance Methods in Protocol and SAP” »

Statistical Data Surveillance

Tools and Automation for SDTM/ADaM Mapping and Validation

Posted on By digi

Tools and Automation for SDTM/ADaM Mapping and Validation In the realm of clinical trials, the importance of adhering to standardized data formats cannot be overstated. Standardized formats such as CDISC’s Study Data Tabulation Model (SDTM) and Analysis Data Model (ADaM) facilitate consistent data collection, management, and analysis across clinical research projects. This article provides a…

Read More “Tools and Automation for SDTM/ADaM Mapping and Validation” »

Data Standards (CDISC: SDTM, ADaM)

Case Studies: Standards-Driven Programs That Reduced Cycle Times

Posted on By digi

Case Studies: Standards-Driven Programs That Reduced Cycle Times In the realm of clinical trials, the emphasis on efficiency and accuracy has never been more paramount. With increasing pressure on clinical operations professionals to deliver quality data at faster rates, understanding how standards-driven programs can enhance trial efficiency is crucial. This comprehensive guide focuses on key…

Read More “Case Studies: Standards-Driven Programs That Reduced Cycle Times” »

Data Standards (CDISC: SDTM, ADaM)

Maintaining Trial Integrity and Confidentiality During Interim Looks

Posted on By digi

Maintaining Trial Integrity and Confidentiality During Interim Looks Maintaining Trial Integrity and Confidentiality During Interim Looks Interim analyses play a critical role in the management and oversight of clinical trials. Ensuring the integrity and confidentiality of these analyses is imperative for the credibility of clinical research outcomes. With the increasing complexity of clinical trials, especially…

Read More “Maintaining Trial Integrity and Confidentiality During Interim Looks” »

Interim Analyses & Alpha Spending

Regulatory Views on Statistical Data Surveillance in RBM Programs

Posted on By digi

Regulatory Views on Statistical Data Surveillance in RBM Programs Regulatory Views on Statistical Data Surveillance in RBM Programs Introduction to Statistical Data Surveillance in Risk-Based Monitoring In the evolving landscape of clinical trials, especially in the context of at home clinical trials, organizations must focus on risk-based monitoring (RBM) as a critical strategy to enhance…

Read More “Regulatory Views on Statistical Data Surveillance in RBM Programs” »

Statistical Data Surveillance

Handling Non-Standard Data: Devices, Digital Biomarkers and RWD

Posted on By digi

Handling Non-Standard Data: Devices, Digital Biomarkers and RWD Handling Non-Standard Data: Devices, Digital Biomarkers and RWD Clinical trials play a vital role in advancing medical knowledge and improving patient outcomes. However, the landscape of data management is continuously evolving, particularly with the integration of non-standard data sources such as devices, digital biomarkers, and real-world data…

Read More “Handling Non-Standard Data: Devices, Digital Biomarkers and RWD” »

Data Standards (CDISC: SDTM, ADaM)

Regulatory Expectations for CDISC Conformance in US, EU and Japan

Posted on By digi

Regulatory Expectations for CDISC Conformance in US, EU and Japan As clinical research continues to evolve, the need for standardized data reporting and submission processes becomes imperative. Central to this effort is the Clinical Data Interchange Standards Consortium (CDISC), which provides pivotal guidelines for clinical data management and submission. This article serves as a comprehensive…

Read More “Regulatory Expectations for CDISC Conformance in US, EU and Japan” »

Data Standards (CDISC: SDTM, ADaM)

Blinded vs Unblinded Interim Analyses: Operational and Regulatory Risks

Posted on By digi

Blinded vs Unblinded Interim Analyses: Operational and Regulatory Risks Blinded vs Unblinded Interim Analyses: Operational and Regulatory Risks In the realm of clinical trials, particularly adaptive platform trials, interim analyses serve as critical checkpoints that can influence the overall study trajectory. This tutorial aims to provide an in-depth understanding of the operational and regulatory risks…

Read More “Blinded vs Unblinded Interim Analyses: Operational and Regulatory Risks” »

Interim Analyses & Alpha Spending